RecruitingNCT06195059

Contrast Echocardiography During Exercise to Assess Pulmonary Blood Volume

Assessment of Pulmonary Blood Volume Using Contrast Echocardiography During Exercise


Sponsor

Mayo Clinic

Enrollment

800 participants

Start Date

Jul 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to evaluate whether pulmonary blood volume (PBV) derived from contrast echocardiography can serve as a non-invasive surrogate for invasive pulmonary artery wedge pressure (PAWP) during exercise. Also, to compare changes in PBV with exercise in patients with and without heart failure and pulmonary vascular disease.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients referred to the cardiac catheterization laboratory for invasive exercise right heart catheterization for evaluating exertional dyspnea. Investigators will include patients with normal or low EF, and across the spectrum of pulmonary hypertension severity.

Exclusion Criteria2

  • Patient inability or unwillingness to undergo echocardiography including a contrast method, or if echocardiography would, in the opinion of the investigator, somehow compromise the quality of data acquisition for the clinical case.
  • Prior adverse reaction to echo contrast administration

Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06195059


Related Trials